Gero raises $6M to hack the ageing code and combat age-related diseases
Longevity Technology - 18-Oct-2023Company's quest to decode ageing and develop novel therapies gains momentum
Gero
AI-powered platform for drug discovery and drug repurposing for age-related diseases.
Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues. We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.
Visit website: https://gero.ai/
Details last updated 03-Feb-2020
Gero News
Reason reports back from Age-Related Disease Therapeutics Summit 2023
Fight Aging! - 16-Jun-2023Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022Some really exciting developments with quite a few in clinical trials
New biological ageing clock based on movement data from a wearable device
Lifespan.io (LEAF) - 14-Sep-2021Tracks biological age from physical activity without requiring a blood test
Suppressing bacterial hydrogen sulfide can make potent antibiotics
Phys.org - 10-Jun-2021Enhancement of bactericidal effect at the same antibiotic dose
Display all news
Gero is also referenced in the following:
A Physicist’s Controversial Take on Why Age Reversal Will Never Work | Peter Fedichev
The Harsh Truth About Age Reversal – Peter Fedichev’s Scientific Rebuttal
Gero Creations
GeroSense AI
Digital biomarker for biological age and resilience to assess lifestyle, nutraceutical and therapeutic interventions
People at Gero
-thumbnail-AC.jpg)
